Sundry Photography/iStock Editorial via Getty Images

Boston Scientific’s (NYSE:BSX) planned merger with Axonics (NASDAQ:AXNX) is now expected to close in the second half of the year after the companies received a request from the U.S. Federal Trade Commission (FTC) for additional information pertaining to the

Source link

Previous articleMissouri Voters Vote Against Wealth Redistribution
Next articleDave & Buster’s: Free Kids Meal with Adult Food Purchase!


Please enter your comment!
Please enter your name here